Long-term cardiomyopathy risk varies by chemo agent
(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according
Read more
AHA: Update on Diagnosis, Tx for Chagas Cardiomyopathy
TUESDAY, Sept. 11, 2018 — Health care providers need to be equipped to recognize, diagnose, and treat Chagas disease, which
Read more